Multiple Intracerebral Doses of Neural Stem Cell-Based Virotherapy (NSC-CRAd-S-pk7) for the Treatment of Recurrent High-Grade Gliomas

Clinical trial NCT05139056 · SUSPENDED

Trial details

NCT number: NCT05139056
Sponsor: City of Hope Medical Center
Status: SUSPENDED
Phase: Phase 1
Study type: INTERVENTIONAL

Currently Only Enrolling Glioblastoma Patients at First Recurrence

Start date: 2023-05-02
Primary completion: 2026-08-07
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.